Lennar CorporationLennar faces declining demand with a 9.2% average backlog drop over two years and 8.9% annual EPS decline.
StockStory identifies Lennar as a risky S&P 500 stock to sell, while naming PTC and AbbVie as promising stocks to watch. Lennar faces declining demand with a 9.2% average backlog drop over two years and an 8.9% annual earnings per share decline over five years, despite revenue growth. PTC shows strength with 21% average billings growth, an 84.7% gross margin, and a 38.7% operating margin. AbbVie benefits from a $62.82 billion revenue base, strong free cash flow, and a 17.5% return on invested capital.
Lennar CorporationLennar faces declining demand with a 9.2% average backlog drop over two years and 8.9% annual EPS decline.
AbbVie IncAbbVie is highlighted as promising due to strong financial metrics: $62.82B revenue, high free cash flow, and 17.5% ROIC.
PTC IncPTC shows strength with 21% average billings growth, 84.7% gross margin, and 38.7% operating margin.